Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System

Abstract Purpose To evaluate access site adverse events following ClotTriever-mediated large-bore mechanical thrombectomy via small upper extremity deep veins (< 6-mm). Materials and methods Twenty patients, including 24 upper extremity venous access sites, underwent ClotTriever-mediated large-bo...

Full description

Saved in:
Bibliographic Details
Main Authors: Luke A. Verst, Colvin Greenberg, David S. Shin, Matthew Abad-Santos, Eric J. Monroe, Mina S. Makary, Jeffrey Forris Beecham Chick
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:CVIR Endovascular
Online Access:https://doi.org/10.1186/s42155-024-00509-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544311181672448
author Luke A. Verst
Colvin Greenberg
David S. Shin
Matthew Abad-Santos
Eric J. Monroe
Mina S. Makary
Jeffrey Forris Beecham Chick
author_facet Luke A. Verst
Colvin Greenberg
David S. Shin
Matthew Abad-Santos
Eric J. Monroe
Mina S. Makary
Jeffrey Forris Beecham Chick
author_sort Luke A. Verst
collection DOAJ
description Abstract Purpose To evaluate access site adverse events following ClotTriever-mediated large-bore mechanical thrombectomy via small upper extremity deep veins (< 6-mm). Materials and methods Twenty patients, including 24 upper extremity venous access sites, underwent ClotTriever-mediated large-bore thrombectomy of the upper extremity and thoracic central veins for symptomatic deep vein obstruction unresponsive to anticoagulation. Patients without follow-up venous duplex examinations (n = 3) were excluded. Patients who had > 6-mm diameter veins accessed (n = 3) were excluded. Temporary purse-string sutures and manual pressure were used for access site hemostasis in all patients. Vein access site and diameter, technical success (defined as placement of the 13.5-French ClotTriever sheath followed by thrombectomy), and early (< 30-days) and late (> 30-days) access site-related adverse events (according to the Adverse Event Classification by the Society of Interventional Radiology criteria) were recorded. Results Fourteen patients (8 males, 6 females; mean age 51.7 ± 13.6 years) comprising 16 upper extremity venous access sites were included in this study. Access sites included: right brachial (n = 7), left brachial (n = 5), and bilateral brachial (n = 2) veins. The mean access site diameter was 4.3-mm ± 0.67-mm. Technical success was achieved via all access sites. Six (42.9%) patients underwent stent reconstruction following thrombectomy through the same accesses. After the procedure, all purse-string sutures were removed within 24 h. Three (21.4%) patients experienced small access site hematomas that did not require transfusion, intervention, or prolonged hospitalization. Initial follow-up venous duplex ultrasounds were performed at 29.3 ± 21.7 days following intervention. The mean follow-up interval to the second and third venous duplex ultrasounds were 124.3 ± 64-days and 225.1 ± 80.1 days, respectively. One (7.1%) patient developed right arm swelling six days after the procedure and was found to have thrombosis of the previously accessed right brachial vein. No other clinically or sonographically significant access site adverse events were observed. Conclusion ClotTriever-mediated large-bore thrombectomy via small upper extremity veins is safe with minimal access site adverse events.
format Article
id doaj-art-bf5bf3e86e49453f9d3add61b66c6585
institution Kabale University
issn 2520-8934
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series CVIR Endovascular
spelling doaj-art-bf5bf3e86e49453f9d3add61b66c65852025-01-12T12:41:21ZengSpringerOpenCVIR Endovascular2520-89342025-01-01811610.1186/s42155-024-00509-8Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy SystemLuke A. Verst0Colvin Greenberg1David S. Shin2Matthew Abad-Santos3Eric J. Monroe4Mina S. Makary5Jeffrey Forris Beecham Chick6Department of Radiology, Section of Vascular and Interventional Radiology, University of WashingtonDepartment of Radiology, Section of Vascular and Interventional Radiology, University of WashingtonDepartment of Radiology, Division of Vascular and Interventional Radiology, University of Southern CaliforniaDepartment of Radiology, Section of Vascular and Interventional Radiology, University of WashingtonDepartment of Radiology, Section of Vascular and Interventional Radiology, University of WisconsinDepartment of Radiology, Division of Vascular and Interventional Radiology, The Ohio State University Wexner Medical CenterDepartment of Radiology, Section of Vascular and Interventional Radiology, University of WashingtonAbstract Purpose To evaluate access site adverse events following ClotTriever-mediated large-bore mechanical thrombectomy via small upper extremity deep veins (< 6-mm). Materials and methods Twenty patients, including 24 upper extremity venous access sites, underwent ClotTriever-mediated large-bore thrombectomy of the upper extremity and thoracic central veins for symptomatic deep vein obstruction unresponsive to anticoagulation. Patients without follow-up venous duplex examinations (n = 3) were excluded. Patients who had > 6-mm diameter veins accessed (n = 3) were excluded. Temporary purse-string sutures and manual pressure were used for access site hemostasis in all patients. Vein access site and diameter, technical success (defined as placement of the 13.5-French ClotTriever sheath followed by thrombectomy), and early (< 30-days) and late (> 30-days) access site-related adverse events (according to the Adverse Event Classification by the Society of Interventional Radiology criteria) were recorded. Results Fourteen patients (8 males, 6 females; mean age 51.7 ± 13.6 years) comprising 16 upper extremity venous access sites were included in this study. Access sites included: right brachial (n = 7), left brachial (n = 5), and bilateral brachial (n = 2) veins. The mean access site diameter was 4.3-mm ± 0.67-mm. Technical success was achieved via all access sites. Six (42.9%) patients underwent stent reconstruction following thrombectomy through the same accesses. After the procedure, all purse-string sutures were removed within 24 h. Three (21.4%) patients experienced small access site hematomas that did not require transfusion, intervention, or prolonged hospitalization. Initial follow-up venous duplex ultrasounds were performed at 29.3 ± 21.7 days following intervention. The mean follow-up interval to the second and third venous duplex ultrasounds were 124.3 ± 64-days and 225.1 ± 80.1 days, respectively. One (7.1%) patient developed right arm swelling six days after the procedure and was found to have thrombosis of the previously accessed right brachial vein. No other clinically or sonographically significant access site adverse events were observed. Conclusion ClotTriever-mediated large-bore thrombectomy via small upper extremity veins is safe with minimal access site adverse events.https://doi.org/10.1186/s42155-024-00509-8
spellingShingle Luke A. Verst
Colvin Greenberg
David S. Shin
Matthew Abad-Santos
Eric J. Monroe
Mina S. Makary
Jeffrey Forris Beecham Chick
Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
CVIR Endovascular
title Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
title_full Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
title_fullStr Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
title_full_unstemmed Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
title_short Safety of accessing brachial veins for large-bore upper extremity venous thrombectomy using ClotTriever Thrombectomy System
title_sort safety of accessing brachial veins for large bore upper extremity venous thrombectomy using clottriever thrombectomy system
url https://doi.org/10.1186/s42155-024-00509-8
work_keys_str_mv AT lukeaverst safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT colvingreenberg safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT davidsshin safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT matthewabadsantos safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT ericjmonroe safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT minasmakary safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem
AT jeffreyforrisbeechamchick safetyofaccessingbrachialveinsforlargeboreupperextremityvenousthrombectomyusingclottrieverthrombectomysystem